Protease-deleted adenovirus as an alternative for replication-competent adenovirus vector
Abstract
No abstract availableKeywords
Funding Information
- National Research Council Canada
This publication has 53 references indexed in Scilit:
- Effects of the Deletion of Early Region 4 (E4) Open Reading Frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on Virus-Host Cell Interaction, Transgene Expression, and Immunogenicity of Replicating Adenovirus HIV Vaccine VectorsPLOS ONE, 2013
- Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectorsVeterinary Research, 2013
- Replicating and non-replicating viral vectors for vaccine developmentCurrent Opinion in Biotechnology, 2007
- Improvement of Antitumor Activity by Gene Amplification with a Replicating but Nondisseminating AdenovirusCancer Research, 2007
- Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer AntibodiesJournal of Virology, 2005
- Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus proteaseGene Therapy, 2002
- Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12Human Gene Therapy, 1996
- Characterization of an Adenovirus Gene Transfer Vector Containing an E4 DeletionHuman Gene Therapy, 1995
- Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporterVirus Research, 1993
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977